Zymergen Inc. Common Stock
ZY was delisted on the 18th of October, 2022.
86 hedge funds and large institutions have $168M invested in Zymergen Inc. Common Stock in 2022 Q3 according to their latest regulatory filings, with 27 funds opening new positions, 18 increasing their positions, 18 reducing their positions, and 21 closing their positions.
135% more capital invested
Capital invested by funds: $71.4M → $168M (+$96.7M)
67% more call options, than puts
Call options by funds: $809K | Put options by funds: $484K
29% more first-time investments, than exits
New positions opened: 27 | Existing positions closed: 21
6% more funds holding
Funds holding: 81 → 86 (+5)
0% more repeat investments, than reductions
Existing positions increased: 18 | Existing positions reduced: 18
40% less funds holding in top 10
Funds holding in top 10: 5 → 3 (-2)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
AIM
ARK Investment Management
St. Petersburg,
Florida
|
+$9.77M |
| 2 |
Morgan Stanley
New York
|
+$2.88M |
| 3 |
E
Ergoteles
New York
|
+$1.58M |
| 4 |
NYLIM
New York Life Investment Management
New York
|
+$1.5M |
| 5 |
Vanguard Group
Malvern,
Pennsylvania
|
+$1.35M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Millennium Management
New York
|
-$4.45M |
| 2 |
JP Morgan Chase
New York
|
-$4.14M |
| 3 |
D.E. Shaw & Co
New York
|
-$2.34M |
| 4 |
TSV
Two Sigma Ventures
New York
|
-$1.86M |
| 5 |
PA
Perceptive Advisors
New York
|
-$1.09M |
ZY Hedge Fund Activity: Q3 2022 in Review
86 of the 5,828 institutional investors tracked by Wall St. Rank reported a position in Zymergen Inc. Common Stock (ZY) for Q3 2022, worth a combined $168M — up 135% from $71.4M a quarter earlier.
Buyers outnumbered sellers: 27 funds opened new ZY positions and 21 closed out — a net gain of 6 holders — while 18 added to existing stakes and 18 trimmed.
The largest buyer was ARK Investment Management, adding an estimated $9.77M. The largest seller was Millennium Management, cutting an estimated $4.45M.
- 86 institutional investors held Zymergen Inc. Common Stock (ZY) as of Q3 2022, up from 81 in Q2 2022.
- Funds reported $168M of Zymergen Inc. Common Stock stock for Q3 2022, up 135% quarter-over-quarter.
- 27 funds opened new Zymergen Inc. Common Stock positions in Q3 2022 and 21 closed out, a net change of +6 holders.
- The largest Zymergen Inc. Common Stock buyer in Q3 2022 was ARK Investment Management, an estimated $9.77M added.
- The largest Zymergen Inc. Common Stock seller in Q3 2022 was Millennium Management, an estimated $4.45M sold.
Based on aggregated 13F filings for Q3 2022.